Reply to thread

Message: [QUOTE="greenmedinfo, post: 1774"] PMID: J Biomed Nanotechnol. 2018 Oct 1 ;14(10):1806-1815. PMID: 30041726 Abstract Title: Oral Delivery of Bavachinin-Loaded PEG-PLGA Nanoparticles for Asthma Treatment in a Murine Model. Abstract: T helper type 2 (Th2) cytokines, such as interleukin (IL)-4, IL-5, and IL-13, are the central therapeutic targets in the development of drugs against asthma. Recently, it was found that bavachinin, an essential small molecule in Psoralea corylifolia, has very efficient therapeutic function in asthma treatment in a murine model via the selective inhibition of Th2 cytokine production. However, the clinical potential of bavachinin is limited by its extremely low water solubility ( [URL='https://www.greenmedinfo.com/article/oral-delivery-bavachinin-loaded-peg-plga-nanoparticles-asthma-treatment-murine']read more[/URL] [/QUOTE]